Capex.com

Anchored by a global presence and regional expertise, CAPEX is a multi-licensed and multi-product company that holds operating licenses from the Cyprus Securities and Exchange Commission, Abu Dhabi Global Market Financial Services Regulatory Authority, the Financial Sector Conduct Authority in South Africa, and the Seychelles Financial Services Authority. The information presented herein is prepared by CAPEX.com and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.

Recent

NASDAQ 100 forecast for the remaining of 2022 and beyond

NASDAQ 100 forecast for the remaining of 2022 and beyond

The NASDAQ 100 Composite Index has seen a rebound in recent weeks recovering 50% of the 2022 losses but remains in a downtrend due to the weight of accelerating inflation, interest rate hikes, and fears of recession. Will the recent US Tech 100 upward momentum continues and what analyst forecasts for the rest of the year?

270 Views

Author Profile

Capex.com

Capex.com

Anchored by a global presence and regional expertise, CAPEX is a multi-licensed and multi-product company that holds operating licenses from the Cyprus Securities and Exchange Commission, Abu Dhabi Global Market Financial Services Regulatory Authority, the Financial Sector Conduct Authority in South Africa, and the Seychelles Financial Services Authority.


The information presented herein is prepared by CAPEX.com and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.